Stable and unstable forms of human fibroblast interferon

Area of Science:

• Biochemistry
• Immunology
• Molecular Biology

Background:

• Human fibroblast interferon (IFN-β) and human leukocyte interferon (IFN-α) are crucial antiviral proteins.
• Interferons exhibit varying stability and biological activity, influencing their therapeutic potential.
• Glycosylation is a post-translational modification that can significantly impact protein function and stability.

Purpose of the Study:

• To characterize a minor, stable fraction of human fibroblast interferon.
• To investigate the biochemical properties of this stable interferon fraction.
• To explore the potential role of glycosylation in differentiating this fraction from bulk fibroblast interferon.

Main Methods:

• Treatment of fibroblast interferon with guanidine hydrochloride to assess renaturation.
• Antigenic analysis to compare the stable fraction with leukocyte interferon and bulk fibroblast interferon.
• Assay of interferon activity on heterologous cells.
• Inhibition studies using glucosamine to assess its effect on interferon production.

Main Results:

• A minor fraction of human fibroblast interferon demonstrated renaturability after guanidine hydrochloride treatment, similar to leukocyte interferon.
• This stable fraction was antigenically similar to bulk fibroblast interferon and showed low activity on heterologous cells.
• Glucosamine significantly inhibited total interferon production but had a minimal effect on the stable fraction's production.

Conclusions:

• The stable, renaturable interferon fraction likely differs from the bulk fibroblast interferon in its glycosylation.
• Differences in glycosylation may explain the distinct stability and production characteristics of this interferon fraction.
• Further investigation into the glycosylation patterns of interferons could reveal new therapeutic strategies.